NKTR logo

Nektar Therapeutics (NKTR) Operating Profit

Annual Operating Profit:

-$129.92M+$5.31M(+3.92%)
December 31, 2024

Summary

  • As of today, NKTR annual operating income is -$129.92 million, with the most recent change of +$5.31 million (+3.92%) on December 31, 2024.
  • During the last 3 years, NKTR annual operating profit has risen by +$316.19 million (+70.88%).
  • NKTR annual operating profit is now -118.89% below its all-time high of $687.93 million, reached on December 31, 2018.

Performance

NKTR Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

Quarterly Operating Profit:

-$31.53M+$4.25M(+11.88%)
September 30, 2025

Summary

  • As of today, NKTR quarterly operating income is -$31.53 million, with the most recent change of +$4.25 million (+11.88%) on September 30, 2025.
  • Over the past year, NKTR quarterly operating profit has increased by +$2.77 million (+8.07%).
  • NKTR quarterly operating profit is now -103.24% below its all-time high of $973.60 million, reached on June 30, 2018.

Performance

NKTR Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

TTM Operating Profit:

-$136.36M+$2.77M(+1.99%)
September 30, 2025

Summary

  • As of today, NKTR TTM operating income is -$136.36 million, with the most recent change of +$2.77 million (+1.99%) on September 30, 2025.
  • Over the past year, NKTR TTM operating profit has dropped by -$467.00 thousand (-0.34%).
  • NKTR TTM operating profit is now -114.38% below its all-time high of $948.29 million, reached on June 30, 2018.

Performance

NKTR TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

NKTR Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+3.9%+8.1%-0.3%
3Y3 Years+70.9%+15.8%+56.3%
5Y5 Years+70.5%+69.4%+64.0%

NKTR Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+70.9%-27.8%+28.9%-5.0%+56.3%
5Y5-Yearat high+70.9%-27.8%+72.6%-5.0%+69.8%
All-TimeAll-Time-118.9%+70.9%-103.2%+73.9%-114.4%+69.8%

NKTR Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
-$31.53M(+11.9%)
-$136.36M(+2.0%)
Jun 2025
-
-$35.78M(+19.3%)
-$139.13M(+0.5%)
Mar 2025
-
-$44.37M(-79.8%)
-$139.83M(-7.6%)
Dec 2024
-$129.92M(+3.9%)
-$24.68M(+28.0%)
-$129.92M(+4.4%)
Sep 2024
-
-$34.30M(+6.0%)
-$135.90M(-0.6%)
Jun 2024
-
-$36.48M(-5.9%)
-$135.10M(-1.8%)
Mar 2024
-
-$34.45M(-12.4%)
-$132.66M(+1.9%)
Dec 2023
-$135.22M(+43.7%)
-$30.66M(+8.5%)
-$135.22M(+7.0%)
Sep 2023
-
-$33.50M(+1.6%)
-$145.45M(+2.7%)
Jun 2023
-
-$34.05M(+8.0%)
-$149.42M(+7.9%)
Mar 2023
-
-$37.02M(+9.5%)
-$162.17M(+32.5%)
Dec 2022
-$240.24M(+46.1%)
-$40.89M(-9.1%)
-$240.24M(+23.1%)
Sep 2022
-
-$37.47M(+19.9%)
-$312.26M(+19.6%)
Jun 2022
-
-$46.79M(+59.3%)
-$388.38M(+14.0%)
Mar 2022
-
-$115.08M(-1.9%)
-$451.80M(-1.3%)
Dec 2021
-$446.10M(-17.4%)
-$112.91M(+0.6%)
-$446.10M(-0.5%)
Sep 2021
-
-$113.60M(-3.1%)
-$443.91M(-2.4%)
Jun 2021
-
-$110.20M(-0.7%)
-$433.37M(-8.1%)
Mar 2021
-
-$109.39M(+1.2%)
-$400.87M(-5.5%)
Dec 2020
-$379.92M(+13.7%)
-$110.72M(-7.4%)
-$379.92M(-0.3%)
Sep 2020
-
-$103.05M(-32.6%)
-$378.84M(-1.2%)
Jun 2020
-
-$77.71M(+12.1%)
-$374.53M(+8.2%)
Mar 2020
-
-$88.44M(+19.3%)
-$407.79M(+7.3%)
Dec 2019
-$440.04M(-164.0%)
-$109.64M(-11.0%)
-$440.04M(-2.2%)
Sep 2019
-
-$98.74M(+11.0%)
-$430.69M(-0.0%)
Jun 2019
-
-$110.97M(+8.1%)
-$430.59M(-165.8%)
Mar 2019
-
-$120.69M(-20.3%)
$653.98M(-4.9%)
Dec 2018
$687.93M(+1675.6%)
-$100.30M(-1.7%)
$687.93M(-11.8%)
Sep 2018
-
-$98.63M(-110.1%)
$780.17M(-17.7%)
Jun 2018
-
$973.60M(+1222.4%)
$948.29M(+1430.7%)
Mar 2018
-
-$86.74M(-977.1%)
-$71.26M(-82.9%)
Dec 2017
-$43.66M(+61.3%)
-$8.05M(-111.6%)
-$38.96M(+38.2%)
Sep 2017
-
$69.48M(+251.2%)
-$63.05M(+61.9%)
Jun 2017
-
-$45.96M(+15.6%)
-$165.44M(-4.8%)
Mar 2017
-
-$54.44M(-69.4%)
-$157.81M(-39.8%)
Dec 2016
-$112.86M(-284.2%)
-$32.14M(+2.3%)
-$112.85M(-5.4%)
Sep 2016
-
-$32.90M(+14.2%)
-$107.07M(-45.2%)
Jun 2016
-
-$38.33M(-304.1%)
-$73.75M(+6.5%)
Mar 2016
-
-$9.48M(+64.0%)
-$78.90M(-199.2%)
Dec 2015
-$29.37M(-78.2%)
-$26.36M(-6392.1%)
-$26.37M(+29.7%)
Sep 2015
-
$419.00K(+101.0%)
-$37.49M(-188.4%)
Jun 2015
-
-$43.47M(-201.0%)
$42.41M(-32.6%)
Mar 2015
-
$43.04M(+214.8%)
$62.96M(+481.9%)
Dec 2014
-$16.48M(+86.3%)
-$37.49M(-146.7%)
-$16.48M(-359.1%)
Sep 2014
-
$80.32M(+450.5%)
-$3.59M(+96.0%)
Jun 2014
-
-$22.92M(+37.0%)
-$90.44M(+9.7%)
Mar 2014
-
-$36.40M(-48.0%)
-$100.13M(+8.2%)
Dec 2013
-$120.13M(+13.9%)
-$24.59M(-276.9%)
-$109.13M(+14.7%)
Sep 2013
-
-$6.53M(+80.0%)
-$127.92M(+17.1%)
Jun 2013
-
-$32.60M(+28.2%)
-$154.29M(-3.8%)
Mar 2013
-
-$45.40M(-4.7%)
-$148.67M(-6.6%)
Dec 2012
-$139.53M(-12.6%)
-$43.38M(-31.9%)
-$139.53M(-6.8%)
Sep 2012
-
-$32.90M(-21.9%)
-$130.61M(-9.7%)
Jun 2012
-
-$26.99M(+25.6%)
-$119.05M(+5.8%)
Mar 2012
-
-$36.26M(-5.2%)
-$126.33M(-1.9%)
Dec 2011
-$123.94M(-690.5%)
-$34.47M(-61.5%)
-$123.94M(-27.2%)
Sep 2011
-
-$21.34M(+37.7%)
-$97.43M(-18.4%)
Jun 2011
-
-$34.26M(-1.2%)
-$82.32M(-78.2%)
Mar 2011
-
-$33.87M(-325.3%)
-$46.19M(-194.6%)
Dec 2010
-$15.68M(+83.5%)
-$7.96M(-27.9%)
-$15.68M(-18.7%)
Sep 2010
-
-$6.22M(-433.4%)
-$13.21M(+63.1%)
Jun 2010
-
$1.87M(+155.6%)
-$35.84M(+47.4%)
Mar 2010
-
-$3.36M(+38.9%)
-$68.19M(+28.3%)
DateAnnualQuarterlyTTM
Dec 2009
-$95.13M(-17.2%)
-$5.50M(+81.0%)
-$95.13M(+27.2%)
Sep 2009
-
-$28.86M(+5.3%)
-$130.59M(+4.2%)
Jun 2009
-
-$30.48M(-0.6%)
-$136.30M(+2.1%)
Mar 2009
-
-$30.30M(+26.0%)
-$139.18M(+7.7%)
Dec 2008
-$81.19M(-124.6%)
-$40.96M(-18.5%)
-$150.77M(-24.0%)
Sep 2008
-
-$34.56M(-3.6%)
-$121.63M(-14.1%)
Jun 2008
-
-$33.36M(+20.4%)
-$106.64M(-13.2%)
Mar 2008
-
-$41.89M(-254.5%)
-$94.16M(-20.3%)
Dec 2007
-$36.15M(+77.3%)
-$11.82M(+39.6%)
-$78.24M(+20.4%)
Sep 2007
-
-$19.57M(+6.3%)
-$98.33M(+3.1%)
Jun 2007
-
-$20.88M(+19.6%)
-$101.44M(+19.5%)
Mar 2007
-
-$25.97M(+18.6%)
-$126.06M(+5.4%)
Dec 2006
-$159.23M(+8.9%)
-$31.91M(-40.7%)
-$133.27M(+2.6%)
Sep 2006
-
-$22.68M(+50.2%)
-$136.88M(+0.5%)
Jun 2006
-
-$45.50M(-37.2%)
-$137.57M(-16.1%)
Mar 2006
-
-$33.17M(+6.6%)
-$118.52M(-8.3%)
Dec 2005
-$174.77M(-136.4%)
-$35.52M(-52.0%)
-$109.43M(-18.6%)
Sep 2005
-
-$23.37M(+11.7%)
-$92.31M(-4.9%)
Jun 2005
-
-$26.45M(-9.8%)
-$87.98M(-6.5%)
Mar 2005
-
-$24.09M(-30.9%)
-$82.64M(-7.8%)
Dec 2004
-$73.94M(-11.7%)
-$18.40M(+3.4%)
-$76.68M(+1.9%)
Sep 2004
-
-$19.04M(+9.8%)
-$78.19M(-6.7%)
Jun 2004
-
-$21.12M(-16.5%)
-$73.29M(-9.8%)
Mar 2004
-
-$18.13M(+8.9%)
-$66.77M(-0.9%)
Dec 2003
-$66.19M(+33.9%)
-$19.91M(-40.9%)
-$66.19M(+9.2%)
Sep 2003
-
-$14.13M(+3.2%)
-$72.92M(+12.5%)
Jun 2003
-
-$14.60M(+16.7%)
-$83.37M(+8.8%)
Mar 2003
-
-$17.54M(+34.2%)
-$91.44M(+6.2%)
Dec 2002
-$100.08M(+9.6%)
-$26.64M(-8.4%)
-$97.48M(+16.2%)
Sep 2002
-
-$24.58M(-8.4%)
-$116.29M(+3.3%)
Jun 2002
-
-$22.68M(+3.8%)
-$120.20M(+2.8%)
Mar 2002
-
-$23.58M(+48.1%)
-$123.66M(-0.2%)
Dec 2001
-$110.70M(-73.4%)
-$45.45M(-59.5%)
-$123.35M(-28.8%)
Sep 2001
-
-$28.49M(-9.0%)
-$95.73M(-15.1%)
Jun 2001
-
-$26.14M(-12.3%)
-$83.18M(-15.0%)
Mar 2001
-
-$23.27M(-30.5%)
-$72.35M(-13.3%)
Dec 2000
-$63.85M(-108.7%)
-$17.84M(-11.9%)
-$63.85M(-13.8%)
Sep 2000
-
-$15.94M(-4.2%)
-$56.10M(-17.4%)
Jun 2000
-
-$15.30M(-3.6%)
-$47.80M(-22.0%)
Mar 2000
-
-$14.77M(-46.4%)
-$39.16M(-28.0%)
Dec 1999
-$30.59M(-39.1%)
-$10.09M(-32.2%)
-$30.59M(-11.9%)
Sep 1999
-
-$7.63M(-14.5%)
-$27.35M(-6.9%)
Jun 1999
-
-$6.67M(-7.6%)
-$25.59M(-11.7%)
Mar 1999
-
-$6.20M(+9.4%)
-$22.91M(-4.2%)
Dec 1998
-$21.99M(-60.2%)
-$6.84M(-16.5%)
-$21.99M(-13.1%)
Sep 1998
-
-$5.88M(-47.3%)
-$19.44M(-14.2%)
Jun 1998
-
-$3.99M(+24.4%)
-$17.03M(-4.9%)
Mar 1998
-
-$5.28M(-22.7%)
-$16.23M(-18.5%)
Dec 1997
-$13.72M(-19.3%)
-$4.30M(-24.1%)
-$13.69M(-3.8%)
Sep 1997
-
-$3.46M(-8.6%)
-$13.20M(-6.1%)
Jun 1997
-
-$3.19M(-16.2%)
-$12.43M(-1.5%)
Mar 1997
-
-$2.74M(+27.8%)
-$12.24M(-5.6%)
Dec 1996
-$11.50M(-30.7%)
-$3.80M(-40.7%)
-$11.60M(-12.6%)
Sep 1996
-
-$2.70M(+10.0%)
-$10.30M(-7.3%)
Jun 1996
-
-$3.00M(-42.9%)
-$9.60M(-11.6%)
Mar 1996
-
-$2.10M(+16.0%)
-$8.60M(+2.3%)
Dec 1995
-$8.80M(-54.4%)
-$2.50M(-25.0%)
-$8.80M(-1.1%)
Sep 1995
-
-$2.00M(0.0%)
-$8.70M(-11.5%)
Jun 1995
-
-$2.00M(+13.0%)
-$7.80M(-13.0%)
Mar 1995
-
-$2.30M(+4.2%)
-$6.90M(-23.2%)
Dec 1994
-$5.70M
-$2.40M(-118.2%)
-$5.60M(-75.0%)
Sep 1994
-
-$1.10M(0.0%)
-$3.20M(-52.4%)
Jun 1994
-
-$1.10M(-10.0%)
-$2.10M(-110.0%)
Mar 1994
-
-$1.00M
-$1.00M

FAQ

  • What is Nektar Therapeutics annual operating income?
  • What is the all-time high annual operating profit for Nektar Therapeutics?
  • What is Nektar Therapeutics annual operating profit year-on-year change?
  • What is Nektar Therapeutics quarterly operating income?
  • What is the all-time high quarterly operating profit for Nektar Therapeutics?
  • What is Nektar Therapeutics quarterly operating profit year-on-year change?
  • What is Nektar Therapeutics TTM operating income?
  • What is the all-time high TTM operating profit for Nektar Therapeutics?
  • What is Nektar Therapeutics TTM operating profit year-on-year change?

What is Nektar Therapeutics annual operating income?

The current annual operating profit of NKTR is -$129.92M

What is the all-time high annual operating profit for Nektar Therapeutics?

Nektar Therapeutics all-time high annual operating income is $687.93M

What is Nektar Therapeutics annual operating profit year-on-year change?

Over the past year, NKTR annual operating income has changed by +$5.31M (+3.92%)

What is Nektar Therapeutics quarterly operating income?

The current quarterly operating profit of NKTR is -$31.53M

What is the all-time high quarterly operating profit for Nektar Therapeutics?

Nektar Therapeutics all-time high quarterly operating income is $973.60M

What is Nektar Therapeutics quarterly operating profit year-on-year change?

Over the past year, NKTR quarterly operating income has changed by +$2.77M (+8.07%)

What is Nektar Therapeutics TTM operating income?

The current TTM operating profit of NKTR is -$136.36M

What is the all-time high TTM operating profit for Nektar Therapeutics?

Nektar Therapeutics all-time high TTM operating income is $948.29M

What is Nektar Therapeutics TTM operating profit year-on-year change?

Over the past year, NKTR TTM operating income has changed by -$467.00K (-0.34%)
On this page